Revolution Medicines, Inc.
RVMD
$203.71
$1.710.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 84.26% | -9.25% | -11.52% | 24.66% | 34.35% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 130.13% | 87.51% | 28.76% | 55.04% | 15.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 85.09% | -7.81% | -10.85% | 25.23% | 33.96% |
|
|
|||||
| Total Current Assets | 85.09% | -7.81% | -10.85% | 25.23% | 33.96% |
| Net Property, Plant & Equipment | 10.47% | 12.90% | 16.54% | 68.81% | 46.19% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -0.60% | -1.07% | -1.54% | -1.88% | -1.87% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 75.66% | 221.13% | 149.23% | 177.88% | 212.57% |
| Total Assets | 77.94% | -4.72% | -7.97% | 27.73% | 34.35% |
|
|
|||||
| Total Accounts Payable | 55.77% | 69.53% | 18.72% | 206.06% | 93.60% |
| Total Accrued Expenses | 113.39% | 94.12% | 109.81% | 90.54% | 70.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 28.00% | 27.98% | 27.94% | 94.45% | 57.08% |
| Total Finance Division Other Current Liabilities | 1,013.64% | 400.92% | 1,247.86% | 544.84% | -29.68% |
| Total Other Current Liabilities | 1,013.64% | 400.92% | 1,247.86% | 544.84% | -29.68% |
| Total Current Liabilities | 91.87% | 82.60% | 77.18% | 121.55% | 75.19% |
|
|
|||||
| Total Current Liabilities | 91.87% | 82.60% | 77.18% | 121.55% | 75.19% |
| Long-Term Debt | 322.71% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.07% | 15.37% | 15.66% | 81.50% | 51.37% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1,171.44% | 501.56% | 255.88% | 42.91% | 187.47% |
| Total Liabilities | 204.33% | 162.47% | 146.75% | 233.01% | 197.59% |
|
|
|||||
| Common Stock & APIC | 61.93% | 19.76% | 12.38% | 31.95% | 35.09% |
| Retained Earnings | -80.41% | -70.30% | -65.10% | -62.27% | -58.55% |
| Treasury Stock & Other | -556.99% | -136.44% | 145.04% | -18.26% | 169.89% |
| Total Common Equity | 39.72% | -27.82% | -27.98% | 1.95% | 15.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 39.72% | -27.82% | -27.98% | 1.95% | 15.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 39.72% | -27.82% | -27.98% | 1.95% | 15.23% |
|
|
|||||